Five members rotate off the NCI Board of Scientific Advisors

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Five members are rotating off THE NCI BOARD OF SCIENTIFIC ADVISORS. They are: Todd Golub, (chair), chief scientific officer at the Broad Institute of Massachusetts Institute of Technology and Harvard University.Curt Civin, director of the Center for Stem Cell Biology and a regenerative medicine professor of pediatrics and physiology associate dean for research at the...

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

I have spent over 20 years running a tumor imaging metrics core at an academic cancer center. In that time, I have watched clinical trial enrollment concentrate at a relatively small number of flagship academic institutions. Unfortunately, trials do not propagate well to the community sites where most patients prefer to receive care. The explanations usually offered for why this happens have never fully accounted for what I observed.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login